SOPHiA GENETICS SA Total Liabilities and Share Holders Equity 2020-2024 | SOPH

SOPHiA GENETICS SA total liabilities and share holders equity from 2020 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
SOPHiA GENETICS SA Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $206
2022 $244
2021 $320
2020 $132
2019 $52
SOPHiA GENETICS SA Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-09-30 $178
2024-06-30 $181
2024-03-31 $180
2023-12-31 $206
2023-09-30 $206
2023-06-30 $223
2023-03-31 $232
2022-12-31 $244
2022-09-30 $251
2022-06-30 $277
2022-03-31 $298
2021-12-31 $320
2021-09-30 $335
2021-06-30 $104
2021-03-31 $112
2020-12-31 $132
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $52
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.257B $0.062B
SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $36.709B 54.09
Hims & Hers Health (HIMS) United States $11.210B 183.25
Tempus AI (TEM) United States $10.954B 0.00
Inspire Medical Systems (INSP) United States $5.532B 107.78
IRhythm Technologies (IRTC) United States $3.734B 0.00
Privia Health (PRVA) United States $2.941B 245.10
Enovis (ENOV) United States $2.475B 16.49
Clover Health Investments (CLOV) United States $2.095B 0.00
Azenta (AZTA) United States $2.083B 96.98
Omnicell (OMCL) United States $1.845B 40.23
Schrodinger (SDGR) United States $1.580B 0.00
Phreesia (PHR) United States $1.577B 0.00
10x Genomics (TXG) United States $1.381B 0.00
Butterfly Network (BFLY) United States $0.859B 0.00
Fulgent Genetics (FLGT) United States $0.512B 0.00
Standard BioTools (LAB) United States $0.495B 0.00
Talkspace (TALK) United States $0.481B 285.00
TruBridge (TBRG) United States $0.423B 123.26
Nyxoah SA (NYXH) Belgium $0.353B 0.00
Pulmonx (LUNG) United States $0.352B 0.00
Health Catalyst (HCAT) United States $0.305B 0.00
American Well (AMWL) United States $0.174B 0.00
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
MDxHealth SA (MDXH) Belgium $0.085B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
111 (YI) China $0.072B 0.00
CareCloud (CCLD) United States $0.054B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
SHL Telemedicine (SHLT) Israel $0.038B 0.00
Zhongchao (ZCMD) China $0.034B 0.00
Movano (MOVE) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Precipio (PRPO) United States $0.014B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00